Albert Erani Named to Organogenesis Board of Directors.

CANTON, Mass.--(BW Healthwire)--Nov. 13, 1998--Organogenesis Inc. (AMEX:ORG) today announced the election of Albert Erani to its Board of Directors, effective November 10, 1998. Mr. Erani is a significant shareholder in Organogenesis.

Mr. Erani is a co-founder of A&E Stores, Inc., which operates approximately 80 stores. He is a substantial shareholder in Vanlex Stores, Inc. and also holds a major share in three international wholesale apparel companies.

"We are pleased to have Albert join the Board of Directors," said Herbert M. Stein, Chairman and Chief Executive Officer of Organogenesis. "As a successful entrepreneur, Albert brings to the Board proven business acumen, while also providing further representation of the interests of shareholders.

Organogenesis Inc. designs, develops and manufactures medical products containing living cells and/or natural connective tissue. The Company's product development focus includes living tissue replacements, cell-based organ assist devices and other tissue-engineered products. Lead product Apligraf(R) has been approved for the treatment of venous leg ulcers in the US and Canada; Novartis Pharma AG has global Apligraf marketing rights. Organogenesis' portfolio also includes the GRAFTPATCH(TM) surgical product (also FDA-cleared for marketing), Vitrix(TM) connective tissue replacement product, a bioartificial liver, a vascular graft and injectable engineered collagen.